Archives
- o2h ventures launches the first HMRC approved knowledge intensive EIS fund focused on UK biotech therapeutics & AI 11 November, 2020
o2h ventures makes an investment into digital therapeutic Cortirio… 15 October, 2020
Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion 30 June, 2020
o2h ventures makes an investment in Turbine… 15 February, 2020
o2h ventures makes an investment in Pencil Biosciences a novel gene modulation biotech… 15 February, 2020
o2h ventures is pleased to announce an investment in Neurofenix, an innovative digital health company… 15 February, 2020
o2h ventures portfolio company Exonate announces collaboration with Johnson & Johnson 17 January, 2020
Sunil Shah, CEO, o2h discovery Wins Special Recognition Award by OBN UK Ltd 11 November, 2019
o2h ventures makes it to the finals in the Tax Efficiency Awards 17 October, 2019